Cubist Systematic Strategies’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-112,436
Closed -$2.08M 2955
2025
Q1
$2.08M Buy
112,436
+70,268
+167% +$1.27M 0.01% 1391
2024
Q4
$695K Sell
42,168
-101,445
-71% -$1.44M ﹤0.01% 2017
2024
Q3
$2.01M Buy
143,613
+53,521
+59% +$592K 0.01% 1422
2024
Q2
$652K Sell
90,092
-29,134
-24% -$199K ﹤0.01% 1988
2024
Q1
$962K Buy
119,226
+9,696
+9% +$86.8K 0.01% 2203
2023
Q4
$748K Sell
109,530
-21,380
-16% -$119K ﹤0.01% 2284
2023
Q3
$655K Buy
130,910
+106,075
+427% +$735K ﹤0.01% 2156
2023
Q2
$227K Buy
+24,835
New +$231K ﹤0.01% 2755
2023
Q1
Sell
-47,219
Closed -$471K 3897
2022
Q4
$471K Buy
47,219
+17,119
+57% +$190K ﹤0.01% 3065
2022
Q3
$359K Buy
30,100
+19,856
+194% +$199K ﹤0.01% 3408
2022
Q2
$84K Sell
10,244
-34,688
-77% -$297K ﹤0.01% 4010
2022
Q1
$357K Buy
44,932
+4,432
+11% +$38.3K ﹤0.01% 2735
2021
Q4
$379K Buy
40,500
+36,432
+896% +$437K ﹤0.01% 2642
2021
Q3
$64K Sell
4,068
-990
-20% -$17.8K ﹤0.01% 2812
2021
Q2
$109K Sell
5,058
-2,143
-30% -$43.3K ﹤0.01% 2709
2021
Q1
$146K Buy
7,201
+2,504
+53% +$49.5K ﹤0.01% 2566
2020
Q4
$84K Sell
4,697
-7,495
-61% -$110K ﹤0.01% 2421
2020
Q3
$142K Sell
12,192
-17,985
-60% -$209K ﹤0.01% 2222
2020
Q2
$279K Buy
30,177
+16,800
+126% +$151K ﹤0.01% 1882
2020
Q1
$139K Buy
13,377
+12,232
+1,068% +$156K ﹤0.01% 1831
2019
Q4
$20K Sell
1,145
-30,616
-96% -$452K ﹤0.01% 2343
2019
Q3
$396K Buy
31,761
+11,690
+58% +$193K 0.01% 1413
2019
Q2
$397K Buy
20,071
+13,846
+222% +$296K 0.01% 1626
2019
Q1
$131K Buy
+6,225
New +$114K ﹤0.01% 1934
2018
Q1
Sell
-1,761
Closed -$50K 1832
2017
Q4
$50K Buy
+1,761
New +$41.6K ﹤0.01% 1778

Other funds holding AXGN

Cubist Systematic Strategies's AXGN Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of Axogen (AXGN) in Q2 2025, closing a stake of 112,436 shares — an estimated $2.08M sold.

Cubist Systematic Strategies first reported a position in AXGN in Q4 2017 and held it in 25 quarters. The position peaked at $2.08M in Q1 2025. 155 funds tracked by Wall St. Rank hold AXGN as of Q2 2025.

  • Cubist Systematic Strategies reported no remaining Axogen position as of Q2 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 112,436 Axogen shares in Q2 2025, an estimated $2.08M.
  • Cubist Systematic Strategies first reported a position in Axogen in Q4 2017 and held it in 25 quarters.
  • Cubist Systematic Strategies's Axogen position peaked at $2.08M in Q1 2025.
  • 155 funds tracked by Wall St. Rank held Axogen as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.